Bio prospects for CEO
Tuesday, 23 September, 2008
Peter May has been appointed as the new CEO of Brisbane agribiotech BioProspect, taking over from Warwick Dowse, who has returned to New Zealand.
May has previously worked with CFL, Incitec and Crop Care Australasia, and has run his own consultancy since 2001, working with the likes of Syngenta. He will officially take up the job on November 3.
BioProspect focuses on the discovery, research and development of commercial products from Australian botanical sources.
It is currently developing two main products: a natural termite compound called Termilone and a range of natural plant extracts for application in the animal nutrition, health and agricultural markets called Bioeffectives.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
